Verastem (VSTM) Operating Expenses (2011 - 2026)

Verastem's Operating Expenses history runs 16 years deep, the most recent figure standing at $63.6 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 43.9% year-over-year to $63.6 million; the TTM figure through Mar 2026 stood at $220.4 million (up 56.26% YoY), while the FY2025 annual figure was $201.0 million, up 60.89% from the prior year.
• Operating Expenses for Q1 2026 stood at $63.6 million, up from $59.0 million in the prior quarter.
• The five-year high for Operating Expenses was $63.6 million in Q1 2026, with the low at $16.8 million in Q4 2022.
• The 5-year median for Operating Expenses is $28.3 million (2024), against an average of $32.8 million.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses fell 5.19% in 2023, then surged 86.8% in 2025.
• Verastem's Operating Expenses stood at $16.8 million in 2022, then jumped by 84.85% to $31.1 million in 2023, then rose by 1.45% to $31.6 million in 2024, then soared by 86.8% to $59.0 million in 2025, then increased by 7.72% to $63.6 million in 2026.
• Business Quant data shows VSTM's Operating Expenses at $63.6 million in Q1 2026, $59.0 million in Q4 2025, and $52.0 million in Q3 2025.